Takeda Pharmaceutical (TAK) Minority Interest (2018 - 2026)

Takeda Pharmaceutical's Minority Interest history runs 9 years deep, the most recent figure standing at $7.7 million for Q1 2026.

• On a quarterly basis, Minority Interest rose 31.31% year-over-year to $7.7 million in Q1 2026; TTM through Mar 2026 was $7.7 million, a 31.31% increase from a year earlier, with the FY2026 full-year figure at $8.0 million, up 36.58% from the prior year.
• Minority Interest advanced to $7.7 million in Q1 2026 per TAK's latest filing, from $7.5 million in the prior quarter.
• Across five years, Minority Interest topped out at $7.7 million in Q1 2026 and bottomed at $3.7 million in Q4 2022.
• The 5-year median for Minority Interest is $4.8 million (2023), against an average of $5.3 million.
• Across the five-year window, Minority Interest tumbled 88.91% in 2022 and surged 32.48% in 2024, its largest moves.
• Year by year, Minority Interest stood at $3.7 million in 2022, then advanced by 23.7% to $4.6 million in 2023, then jumped by 32.48% to $6.0 million in 2024, then rose by 23.56% to $7.5 million in 2025, then gained by 3.35% to $7.7 million in 2026.
• Per Business Quant, the three latest TAK Minority Interest figures stand at $7.7 million (Q1 2026), $7.5 million (Q4 2025), and $6.7 million (Q3 2025).